Join the revolution in human health at Alnylam Pharmaceuticals a leader in the field of RNAi therapeutics

Alnylam is leading the translation of the science of RNAi towards a new class of innovative medicines with peer-reviewed research efforts published in the world’s top scientific journals including Nature, Nature Medicine, and Cell. Founded by scientific pioneers in the field of RNAi and leveraging our expertise and capabilities, Alnylam is a dynamic and diverse place to work. We are building a broad pipeline of novel RNAi therapeutics. Our most advanced program is in Phase II human clinical trials for the treatment of respiratory syncytial virus (RSV) infection. In addition, we are developing RNAi therapeutics for the treatment of influenza, hypercholesterolemia, and liver cancers, amongst other diseases. Alnylam’s leadership position in fundamental patents, technology, and know-how relating to RNAi has enabled us to form major alliances with leading companies including Medtronic, Novartis, Biogen Idec, and Roche.

Alnylam Pharmaceuticals is committed to a diverse workplace. Explore a career with us today! Pharmaceutical jobs. Biotech jobs. Diversity jobs. PharmaDiversity Job Board.

Career Opportunities
Search Jobs click here